- Tripterifordin
-
- $103.00 / 1mg
-
2025-05-07
- CAS:139122-81-9
- Min. Order:
- Purity: 99.46%
- Supply Ability: 10g
- tripterifordin
-
- $3.00 / 1KG
-
2020-01-18
- CAS:139122-81-9
- Min. Order: 1KG
- Purity: 98%
- Supply Ability: 1kg , 5kg, 50kg
|
| tripterifordin Basic information |
Product Name: | tripterifordin | Synonyms: | tripterifordin;Hypodiolide A;TRIPTERIFORDIN; HYPODIOLIDE A;Antriptolactone;Hydroxyodolide;Kauran-18-oic acid, 16,20-dihydroxy-, δ-lactone, (4α)-;ripterifordin;(4S,4aS,6aS,8R,9R,11aS,11bR)-8-hydroxy-4,8-dimethyldodecahydro-1H-6a,9-methano-4,11b-(methanooxymethano)cyclohepta[a]naphthalen-14-one | CAS: | 139122-81-9 | MF: | C20H30O3 | MW: | 318.45 | EINECS: | | Product Categories: | Diterpenoids | Mol File: | 139122-81-9.mol |  |
| tripterifordin Chemical Properties |
Boiling point | 485.1±45.0 °C(Predicted) | density | 1.19±0.1 g/cm3(Predicted) | storage temp. | Store at -20°C | solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | form | Powder | pka | 15.24±0.40(Predicted) |
| tripterifordin Usage And Synthesis |
Uses | Tripterifordin possesses significant anti-HIV replication activities in H9 lymphocyte cells with an EC50?value of 3100 nM, respectively[1]. | Definition | ChEBI: A kaurane diterpenoid that is (5beta,8alpha,13alpha)-18,20-epoxykauran-18-one substituted by a hydroxy group at position 16. Isolated from the roots of Tripterygium wilfordii, it exhibits anti
HIV activity. | target | HIV | Immunology & Inflammation related | References | [1] Kobayashi S,?et al. Syntheses?of (-)-Tripterifordin?and (-)-Neotripterifordin?from?Stevioside.J Org Chem.?2018 Feb 2;83(3):1606-1613. DOI:10.1021/acs.joc.7b02916 |
| tripterifordin Preparation Products And Raw materials |
|